Navigation Links
Questcor Pharmaceuticals Selects BDO USA as its Auditor
Date:3/4/2011

substantially all of its net sales from two indications: the treatment of acute exacerbations of multiple sclerosis in adults and the treatment of infantile spasms in children under two years of age.  Questcor is also implementing plans to commercialize Acthar for use in treating nephrotic syndrome, another on-label indication. Specifically with respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus." Questcor also markets Doral(R) (quazepam), which is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. For more information, please visit www.questcor.com.


'/>"/>
SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Questcor Reports 2010 Financial Results
2. Questcor to Report Fourth Quarter and Full Year 2010 Earnings and Conduct Conference Call on February 23, 2011
3. Questcor Pharmaceuticals Reports Strong Finish to 2010
4. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2011
5. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
6. Questcor to Present at the Maxim Group Growth Conference
7. Questcor Reports Third Quarter 2010 Results
8. Questcor to Present at the 21st Annual Oppenheimer Healthcare Conference
9. Questcor Teams With Child Neurology Foundation (CNF) to Fund Infantile Spasms Scientific Research
10. Questcor and Child Neurology Foundation Support the 2nd Annual Infantile Spasms (IS) Awareness Week
11. Questcor to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015 Codman Neuro*, part of ... a new platform of embolic coils for the treatment ... designed to improve microcatheter stability and provide an optimized ... made here at the Society of NeuroInterventional Surgery (SNIS) ... of framing, filling and finishing coils used during a ...
(Date:7/28/2015)... JOLLA, Calif. , July 28, 2015   ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended June ... U.S. financial markets close. Regulus will ... 4, 2015, at 5:00 pm Eastern Daylight Time to ...
(Date:7/28/2015)... /PRNewswire-USNewswire/ -- Kentucky,s ... after a 2012 law required providers to check a ... yet more evidence that Californians need the same protections, ... Kentucky,s prescription drug abuse legislation took ... 52 percent; opioid prescriptions to doctor-shopping individuals dropped by ...
Breaking Medicine Technology:Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3Study Shows Requiring Prescription Drug Database Use Before Prescribing Powerful, Addictive Medications Critical In Ending Growing Epidemic, says Consumer Watchdog 2
... CIMZIA(R) Data Shows Long-term Improvements in Productivity, Quality of ... at American ... FRANCISCO, Oct. 27 5:00 AM PST -- UCB ... CIMZIA(R),(certolizumab pegol) - the only PEGylated anti-TNF (Tumor Necrosis ...
... As Effective As,Twice-a-Day Linezolid When Used to Treat ... Conn., Oct. 26 Rib-X Pharmaceuticals, Inc.,("Rib-X" or ... development and commercialization of novel antibiotics for the,treatment ... Phase 2 clinical trial with the oral form ...
Cached Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 2CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 3CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 4CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 6CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 7CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 8CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 9CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 10Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting 2Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting 3Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting 4
(Date:7/29/2015)... North Carolina (PRWEB) , ... July 29, 2015 ... ... MetLife, Inc ., a global provider of life insurance, annuities, employee benefits ... Team Challenge North Carolina inclusive sporting event taking place in Charlotte, North ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Indiana is ... It is also the home of Zerorez Indianapolis, which plans to expand across the ... 2013. “2015 is our second full year in business and we should double our ...
(Date:7/29/2015)... ... July 29, 2015 , ... EndoMune ... a chewable version of its EndoMune Jr. probiotic supplement for children ages 3-8. ... that children can enjoy to maintain a healthy balance of beneficial gut bacteria,” ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... Solutions Group, which Breckheimer oversees. In her role, Powers is responsible for driving ... making the announcement, Breckheimer commented, “Gina’s track record as an effective leader within ...
(Date:7/28/2015)... ... 2015 , ... Talking About Your Product Pipeline:, How FDA and SEC Regulate ... EDT, http://www.fdanews.com/productpipeline , When a company has a product in development, whether ... is tightly regulated by the FDA. , At the same time, the SEC requires ...
Breaking Medicine News(10 mins):Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4
... of each altered in people with chronic obstructive ... (HealthDay News) -- A disrupted breathing-swallowing pattern may ... obstructive pulmonary disease (COPD) are at increased risk ... moderate to severe COPD show alterations between normal ...
... on the most lethal aspect of cancer will open ... Anderson Cancer Center with support from a highly competitive ... Graduate Program in Cancer Metastasis Research: Bench to Bedside, ... cancer from its original site to other organs. The ...
... Society of Corporate Compliance and Ethics and Health Care ... reports on AIG bonuses it is surprising to learn ... can give and receive and how they can entertain, ... of Corporate Compliance and Ethics (SCCE) and Health Care ...
... over 25% annually, according to Millennium Research GroupWALTHAM, ... Group,s (MRG,s) US Markets for Large-Joint Reconstructive ... the fastest-growing segment of the large-joint reconstructive implant ... growth rate of over 25%. Hip resurfacing ...
... The California Medical Association (CMA) has officially named EMPLOYERS(R) ... insurance specialist (R) , its workers, ... writer of workers, compensation insurance for small businesses and ... and their practices. As part of the agreement, ...
... 26 New findings published in the April issue of ... an important role in promoting heart and bone health. ... Symposium on the role of soy in health promotion and ... November 9-12, 2008."Much progress has been made in understanding the ...
Cached Medicine News:Health News:Swallowing-Breathing Dysfunction Worsens Lung Disorder 2Health News:M. D. Anderson launches graduate program in cancer metastasis 2Health News:Bonuses May be Big but Don't Expect a Lavish Dinner or Gift 2Health News:Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement 2Health News:Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement 3Health News:California Medical Association Names EMPLOYERS(R) Provider of Choice for its 35,000 Physician Members 2Health News:New Report In The Journal of Nutrition Shows Soy Is Beneficial For Heart and Bone Health 2Health News:New Report In The Journal of Nutrition Shows Soy Is Beneficial For Heart and Bone Health 3
... Practice Partner Patient Records provides a ... both office and clinical efficiency, while ... Patient Records allows practices to replace ... feature set utilized nationwide by over ...
... is one of our leading products. ... software is what Compulink first developed ... among today's leaders in the ophthalmic ... integrates all the functionality of a ...
... Working with over ... is proud to serve ... ophthalmology client bases in ... Intuition PM Ophthalmology, we ...
... ExamWRITER Electronic Medical Records (including ExamDRAW) ... record instrument in the industry. Doctors and ... with effortless speed and accuracy using our ... the need for typing, we have created ...
Medicine Products: